NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from Life Science Investor Forum, held on June 22nd are now available for online viewing.
REGISTER NOW AT: https://bit.ly/3NuvXOW
The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section.
Select companies are accepting 1x1 management meeting requests through June 27, 2023.
|Orexo AB||OTCQX: ORXOY | STO: ORX|
|StarPharma Holdings Limited||OTCQX: SPHRY | ASX: SPL|
|Medinotec Inc.||OTCQX: MDNC|
|ReShape Lifesciences Inc.||NASDAQ: RSLS|
|NervGen Pharma Corp.||OTCQX: NGENF | TSXV: NGEN|
|Genflow Biosciences PLC||OTCQB: GENFF | LSE: GENF|
|Else Nutrition Holdings Inc.||OTCQX: BABYF | TSX: BABY|
|PharmAla Biotech Holdings Inc.||Pink: PMBHF | CSE: MDMA|
|Alpha Cognition Inc.||OTCQB: ACOGF | CSE: ACOG|
|Kiora Pharmaceuticals, Inc.||NASDAQ: KPRX|
To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
OTC Markets Group Inc. +1 (212) 896-4428, firstname.lastname@example.org
Virtual Investor Conferences Contact:
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group